FDA Approves New Rx for Combination with Other HIV Medications
On September 24, 2014, FDA approved Vitekta (elvitegravir) 85 mg and 150 mg tablets.
FDA Approves New Rx for Combination with HIV Medications
On September 24, 2014, FDA approved Tybost (cobicistat) 150 mg tablets. Tybost is a CYP3A inhibitor indicated to increase systemic exposure of atazanavir or darunavir (once daily dosing regimen) in combination with other antiretroviral agents in the treatment of HIV-1 infection.
Recommendations to Reduce STDs Focus on Teens, At-Risk Adults
Sexually transmitted diseases (STDs) continue to be a major health concern. New recommendations call for more measures to address this problem.
HPV Vaccine May Have Staying Power
Not only does the HPV vaccine protect against human papillomavirus, but it also reduces the risk of cancers caused by HPV. Yet it only protects a person if it lasts long enough.
Test May Help Predict HPV-Related Cancers
Cancer can seem unpredictable, but a new study suggests that simple tests may help predict when one type of cancer will come back.
Teen Vaccinations Were up, but HPV Vaccination Still Lagged
Opting for a vaccine that could possibly prevent cancer may seem simple on paper, but families across the nation have been slow to adopt one such vaccine.
International Attention Given to Hepatitis
Having treatment options for a condition is great, but it isn't much help when people don't realize they are ill. This is often the case with hepatitis, say experts trying to raise awareness of the condition through World Hepatitis Day.
New HIV Care Includes Medical and Behavioral Treatment
Human immunodeficiency virus (HIV) is a sexually transmitted disease that can be deadly. HIV infection often goes undetected in patients who do not seek care. However, new research says that there may be new ways to use HIV care so that the virus becomes manageable.
Dual Therapy May Control Hepatitis C in HIV Patients
For patients with human immunodeficiency virus (HIV), hepatitis C (HCV) can also be a problem. A new combination of medications, however, may effectively treat HCV in those with HIV.
HIV Diagnosis Rate Dropped
HIV has been a national concern for years, but new data suggest that serious progress has been made.